FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Will China Ban Growth-promoting Antibiotics?

[ Price : $8.95]

Online food safety reporters cant confirm a report that China plans to ban growth-promoting antibiotics in animal feed.

GlycoMimetic, Pfizer License Agreement on Sickle Cell Drug

[ Price : $8.95]

GlycoMimetics enters into an exclusive worldwide licensing agreement with Pfizer for GMI-1070, a pan-selectin antagonist currently...

Sprycel May Increase Pulmonary Arterial Hypertension Risk: FDA

[ Price : $8.95]

A new FDA safety alert warns that Bristol-Myers Squibb's leukemia drug Sprycel (dasatinib) may increase the risk of pulmonary arte...

NORD Wants Flexible Review Policy

[ Price : $8.95]

The National Organization for Rare Disorders calls on FDA to formalize its historic flexibility in reviewing orphan drugs in an ag...

FDA Reporters Speak of Intimidation, Retaliation

[ Price : $8.95]

As industry has complained for decades, now journalists say they have to fear intimidation and actual retaliation from FDA unless ...

Advaxis Pre-IND Meeting for HER2 Cancer Therapy

[ Price : $8.95]

FDA grants a pre-IND meeting to Advaxis for 11/22 to discuss the initial clinical development plan for ADXS-HER2 and its use in tr...

FDA Clears Canon Retinal Camera

[ Price : $8.95]

FDA clears a Canon USA 510(k) for the CR-2 PLUS Digital Non-Mydriatic Retinal Camera.

FDA, CMS Seek Device Review Pilot Participants

[ Price : $8.95]

Federal Register Notice: FDA and the Centers for Medicare and Medicaid Services are seeking device sponsor participants for a pilo...

No Meeting Planned on Proprietary Name Pilot Program

[ Price : $8.95]

Federal Register Notice: Due to insufficient submissions, FDA will not hold a public meeting on the voluntary pilot program that e...

More Research on Rare Diseases, Products Urged

[ Price : $8.95]

Presenters at an orphan products and rare diseases conference call for more research on therapeutics for rare diseases; agree on t...